Details about the neuroanatomical projections from CA1 to MEApv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88631 Field CA1Medial nucleus of the amygdala posteroventral part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4B-C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88701 Field CA1Medial nucleus of the amygdala posteroventral part light/moderatebiotinylated dextran amine (BDA)
Collator note: uniform terminal field in the MEAp, especially in mode rostral part. See Fig. 7B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Further details associated to record number 88631:
Position of injection: rostro-ventral
Topological position of injection: is contained
Extension of injection outside: none
The injection was performed in: left hemisphere
Position of terminal field: everywhere
Topological position of terminal field: is contained
Extension of terminal field outside: none
The terminal field was found: ipsilateral